CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2

The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Donata, Corleis, Björn, Rauch, Susanne, Roth, Nicole, Mühe, Janine, Halwe, Nico Joel, Ulrich, Lorenz, Fricke, Charlie, Schön, Jacob, Kraft, Anna, Breithaupt, Angele, Wernike, Kerstin, Michelitsch, Anna, Sick, Franziska, Wylezich, Claudia, Hoffmann, Bernd, Thran, Moritz, Thess, Andreas, Mueller, Stefan O., Mettenleiter, Thomas C., Petsch, Benjamin, Dorhoi, Anca, Beer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245475/
https://www.ncbi.nlm.nih.gov/pubmed/34193869
http://dx.doi.org/10.1038/s41467-021-24339-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245475/
https://www.ncbi.nlm.nih.gov/pubmed/34193869
http://dx.doi.org/10.1038/s41467-021-24339-7

Ejemplares similares